Philip A. Iredale
Pfizer (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior, Cannabis and Cannabinoid Research, Ion channel regulation and function, Stress Responses and Cortisol
Most-Cited Works
- → Increases in intracellular calcium via activation of an endogenous P2‐purinoceptor in cultured CHO‐K1 cells(1993)139 cited
- → CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity(2006)131 cited
- → Discovery of Two Clinical Histamine H 3 Receptor Antagonists: trans - N -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- N -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)(2011)107 cited
- → Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys(2007)101 cited
- → Role of Corticotropin‐Releasing Factor Receptor‐1 in Opiate Withdrawal(2000)98 cited
- → Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies.(1999)92 cited
- → Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells.(1996)68 cited
- → Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide Hydrochloride (CP-945,598), a Novel, Potent, and Selective Cannabinoid Type 1 Receptor Antagonist(2008)62 cited
- → Combination of Rimonabant and Donepezil Prolongs Spatial Memory Duration(2007)48 cited